YORK, Pa., March 5, 2014 /PRNewswire/ -- Unilife
Corporation ("Unilife" or "Company") (NASDAQ: UNIS, ASX: UNS),
today announced that its Chairman and CEO, Alan Shortall, will present at the Barclays
Global Healthcare Conference in Miami at 09:00 a.m.
ET on Thursday, March 13,
2014.
The conference presentation will be broadcast over the Internet
as a "live" listen only Webcast. To listen, please go to:
http://ir.unilife.com/events.cfm. An archive of the event will also
be available for those unable to listen live.
About Unilife Corporation
Unilife Corporation (NASDAQ: UNIS / ASX: UNS) is a U.S. based
developer and commercial supplier of injectable drug delivery
systems. Unilife's broad portfolio of proprietary technologies
includes prefilled syringes with automatic needle retraction, drug
reconstitution delivery systems, auto-injectors, wearable
injectors, ocular delivery systems and novel systems. Each of these
innovative and highly differentiated platforms can be customized to
address specific customer, drug and patient requirements. Unilife's
global headquarters and state-of-the-art manufacturing facilities
are located in York, PA. For more
information, please visit www.unilife.com or download the Unilife
IRapp on your iPhone, iPad or Android device.
General: UNIS-G
|
Investor
Contacts
(US):
|
Analyst
Enquiries
|
Investor
Contacts (Australia)
|
|
Todd Fromer / Garth
Russell
|
Lynn
Pieper
|
Jeff
Carter
|
|
KCSA Strategic
Communications
|
Westwicke
Partners
|
Unilife
Corporation
|
|
P: + 1 212-896-1215 /
212-896-1250
|
P: + 1
415-202-5678
|
P: + 61 2 8346
6500
|
SOURCE Unilife Corporation